J.K. Everett

2 ta ish

University of Pennsylvania

1. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

   Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons +35

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.475807

2. CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in <i>TP53</i>

   Karlo Perica, Nayan Jain, Michael Scordo +23

   Maqola20252 iqtibos

   ABIABI:AkademIndex/2026.other.475959